Literature DB >> 22312161

Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.

A Bikker1, A A Kruize, M Wenting, M A Versnel, J W J Bijlsma, F P J G Lafeber, J A G van Roon.   

Abstract

OBJECTIVE: To identify interleukin (IL)-7Rα expression in the labial salivary gland (LSG) of patients with primary Sjögren's syndrome (pSS) and non-Sjögren's syndrome sicca (nSS-sicca) and to study its correlation with glandular inflammation and IL-7 expression.
METHODS: The presence of infiltrating immune cells and IL-7Rα cells in inflamed LSG of patients with pSS (n=12) and nSS-sicca controls (n=7) was studied by immunohistochemistry and fluorescence activated cell sorting analysis upon tissue digestion (n=15 and n=13, respectively). Additionally, the correlations of IL-7Rα cells with hallmark disease parameters of pSS, major infiltrating inflammatory cells and IL-7 were assessed.
RESULTS: In the LSG of patients with pSS increased numbers of IL-7Rα cells were found as compared with nSS-sicca patients. IL7Rα cells strongly correlated with the lymphocytic focus score, IL-7 expression, the decrease in percentage of IgA plasma cells and numbers of CD3 T cells, CD20 B cells, and CD1a and CD208 myeloid dendritic cells. Analysis of isolated cells from the LSG demonstrated strongly increased percentages of IL-7Rα CD3 T cells in pSS as compared with nSS, showing abundant IL-7Rα expression on both CD4 and CD8 T cells. Other CD45 leucocytes and CD45- tissue cells scarcely expressed IL-7Rα. Percentages of IL-7Rα T cells also significantly correlated with glandular inflammation.
CONCLUSIONS: This study shows the presence of increased IL-7Rα T cells in the LSG of patients with pSS and their association with the severity of sialadenitis, disease parameters and IL-7 expression. Considering the immunostimulatory ability of IL-7Rα T cells and IL-7, this suggests that IL-7(R)-dependent T cell-driven immune activation plays an important role in inflammation in pSS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22312161     DOI: 10.1136/annrheumdis-2011-200744

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

Review 1.  Biologic therapy in Sjögren's syndrome.

Authors:  Qin Shao
Journal:  Clin Rheumatol       Date:  2020-10-27       Impact factor: 2.980

2.  Anti-IL-7 receptor-α treatment ameliorates newly established Sjögren's-like exocrinopathy in non-obese diabetic mice.

Authors:  Jing Zhou; Qing Yu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-19       Impact factor: 5.187

Review 3.  Advances in understanding the pathogenesis of primary Sjögren's syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2013-07-16       Impact factor: 20.543

Review 4.  Immunobiology of T Cells in Sjögren's Syndrome.

Authors:  Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

5.  Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice.

Authors:  Jun-O Jin; Toshihisa Kawai; Seunghee Cha; Qing Yu
Journal:  Arthritis Rheum       Date:  2013-08

6.  The status of glucocorticoid-induced leucine zipper protein in the salivary glands in Sjögren's syndrome: predictive and prognostic potentials.

Authors:  Xu Qin; Jun Yao Liu; Rafik Abdelsayed; Xingming Shi; Jack C Yu; Mahmood S Mozaffari; Babak Baban
Journal:  EPMA J       Date:  2016-02-05       Impact factor: 6.543

7.  Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.

Authors:  Sofie L M Blokland; Maarten R Hillen; Fréderique M van Vliet-Moret; Angela Bikker; Wilco de Jager; Aridaman Pandit; Aike A Kruize; Timothy R D J Radstake; Joel A G van Roon
Journal:  RMD Open       Date:  2019-01-11

8.  Interleukin-7 and Toll-like receptor 7 induce synergistic B cell and T cell activation.

Authors:  Angela Bikker; Aike A Kruize; Kim M G van der Wurff-Jacobs; Rogier P Peters; Marije Kleinjan; Frank Redegeld; Wilco de Jager; Floris P J G Lafeber; Joël A G van Roon
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

Review 9.  Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer.

Authors:  Iva Marković; Savvas N Savvides
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

10.  Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.

Authors:  Joanne Ellis; Andre van Maurik; Lea Fortunato; Sophie Gisbert; Keguan Chen; Ann Schwartz; Simon McHugh; Andrew Want; Sara Santos Franco; Joao-Joaquim Oliveira; Jeffrey Price; Alasdair Coles; Kim Brown; Donggang Su; Jenny L Craigen; Jiansong Yang; Sara Brett; Bill Davis; Joseph Cheriyan; Onajite Kousin-Ezewu; Frank Gray; Paul W Thompson; Disala Fernando
Journal:  Br J Clin Pharmacol       Date:  2018-12-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.